Connect with us

Health

10,000 Federal Health Workers to Be Laid Off

Published

on

10,000 Federal Health Workers to Be Laid Off

The Trump administration announced on Thursday that it was laying off 10,000 employees at the Health and Human Services Department as part of a broad reorganization that reflects the priorities of the health secretary, Robert F. Kennedy Jr., and the White House’s drive to shrink the government.

The layoffs are a drastic reduction in personnel for the health department, which had employed about 82,000 people and touches the lives of every American through its oversight of medical care, food and drugs.

The layoffs and reorganization will cut especially deep at two agencies within the department that have been in Mr. Kennedy’s sights: the Food and Drug Administration and the Centers for Disease Control and Prevention. Those agencies are expected to lose roughly 20 percent of their staff members from the latest cuts alone.

Together with previous buyouts and early retirements spurred by Trump administration policies, the move will pare the health department down to about 62,000 employees, the agency said.

The restructuring is intended to bring communications and other functions directly under Mr. Kennedy. And it includes creating a new division called the Administration for a Healthy America.

Advertisement

“We’re going to do more with less,” Mr. Kennedy said, even as he acknowledged that it would be “a painful period for H.H.S.”

Mr. Kennedy asserted that rates of chronic disease rose under the Biden administration even as the government grew. But he did not provide data to back up his claim; experts say that rates of chronic disease have been rising for the past two decades, including under the first Trump administration. Two 2024 analyses of the issue used C.D.C. data from 2020.

The health secretary pitched the changes as a way to refocus the agency on Americans’ health, but did not outline any specifics on how he would reduce rates of diabetes, heart disease or any other conditions.

Inside the affected agencies, stunned employees struggled to absorb the news. Democrats and outside experts said the move would decimate agencies charged with protecting the health and safety of the American public, depriving it of the scientific expertise necessary to respond to current and future biological threats.

“In the middle of worsening nationwide outbreaks of bird flu and measles, not to mention a fentanyl epidemic, Trump is wrecking vital health agencies with the precision of a bull in a china shop,” said Senator Patty Murray, a Washington Democrat who has been a leader on health issues in Congress.

Advertisement

She called Mr. Kennedy’s comments about doing more with less an “absurd suggestion” that “defies common sense.” Her sentiments were echoed by several agency employees, who spoke on the condition of anonymity to avoid retribution.

They said they worried not for themselves, but for the country, expressing concern about what the layoffs would mean for public health and whether putting safety at risk was really what Americans wanted.

Under the plan, the C.D.C., which handles a wide range of health issues including H.I.V./AIDS, tobacco control, maternal health and the distribution of vaccines for children, would return to its “core mission” of infectious disease.

“Converting C.D.C. to an agency solely focused on infectious diseases takes us back to 1948 without realizing that in 2025, the leading causes of death are noncommunicable disease,” said Dr. Anand Parekh, who served in the health department during the Obama administration and is now the chief medical adviser at the Bipartisan Policy Center in Washington.

The C.D.C. will have its work force cut by about 2,400 employees, and will narrow its focus to “preparing for and responding to epidemics and outbreaks,” an H.H.S. fact sheet said. But it will also absorb the health department’s Administration for Strategic Preparedness and Response, which has 1,000 employees and was elevated to its own separate agency under the Biden administration during the coronavirus pandemic.

Advertisement

The reorganization will cut 3,500 jobs from the F.D.A., which approves and oversees the safety of a vast swath of the medications and food people eat and rely on for well-being, the fact sheet said. The cuts are said to be administrative, but some of the roles support research and monitoring of the safety and purity of food and drugs, as well as travel planning for inspectors who investigate overseas food and drug facilities.

The National Institutes of Health will lose 1,200 staff members, and the agency that administers Medicare and Medicaid is expected to lose 300.

All of those agencies tend to operate under their own authority, and Mr. Kennedy has been at odds with all of them. Mr. Kennedy assailed them, and other parts of the department, in a YouTube video.

“When I arrived, I found that over half of our employees don’t even come to work,” he claimed. “H.H.S. has more than 100 communications offices and more than 40 I.T. departments and dozens of procurement offices and nine H.R. departments. In many cases, they don’t even talk to each other. They’re mainly operating in silos.”

Mr. Kennedy’s move to take control of health communications is significant. Currently, agencies including the C.D.C., the N.I.H. and the F.D.A. manage their own communications with the press and the public.

Advertisement

During the first Trump administration, the C.D.C. clashed with the White House, which silenced agency scientists and took control of its public outreach about Covid-19. The agency’s chief spokesman quit in frustration last week, saying the C.D.C. has been muzzled since January, when Mr. Trump returned to office.

The 28 divisions of the Health and Human Services Department will be consolidated into 15 new divisions, according to a statement issued by the department. Mr. Kennedy announced the changes in his video. The staff cuts, reported earlier by The Wall Street Journal, are being made in line with President Trump’s order to carry out the Department of Government Efficiency’s drive to shrink the federal work force.

The plan also includes collapsing 10 regional H.H.S. offices into five.

The department notified union leaders of the “reduction in force” — known as a “RIF” in federal parlance — early Thursday morning by email. The message, obtained by The New York Times, said the layoffs would most likely take effect on May 27 and were “primarily aimed at administrative positions including human resources, information technology, procurement and finance.”

Democrats including Ms. Murray reacted with fury to the cuts. Representative Gerald E. Connolly of Virginia, the top Democrat on the Oversight and Government Reform Committee, said the cuts were troubling amid a bird flu outbreak and an uptick in measles cases.

Advertisement

“This is a grave mistake,” Mr. Connolly said in a statement, “and I have serious concerns about how this will impact Americans’ well-being now and long into the future.”

Republicans seemed to be taking more of a wait-and-see stance. Senator Bill Cassidy, Republican of Louisiana and the chairman of the committee that oversees health, said he had breakfast with Mr. Kennedy on Thursday. Mr. Cassidy suggested he was open to the reorganization but expected the two “would have more conversations” about specific cuts as their effects became clearer.

Doreen Greenwald, the president of the National Treasury Employees Union, which represents 18,500 H.H.S. staff members across the country, issued a statement vowing to “pursue every opportunity to fight back on behalf of these dedicated civil servants.”

“The administration’s claims that such deep cuts to the Food and Drug Administration and other critical H.H.S. offices won’t be harmful are preposterous,” Ms. Greenwald said.

Xavier Becerra, who served as health secretary under President Joseph R. Biden Jr., issued a statement saying the cuts would most likely downgrade services to elderly and disabled people, and those with mental health challenges, in addition to preparedness for health crises.

Advertisement

“This has the makings of a man-made disaster,” he said on social media.

Mr. Kennedy suggested in the video that the changes would help his team get more access to data. That prospect has been worrisome to his critics, given Mr. Kennedy’s long history of manipulating figures to advance arguments about what he contends are the risks of vaccines that have widely been deemed safe.

“In one case,” Mr. Kennedy said, “defiant bureaucrats impeded the secretary’s office from accessing the closely guarded databases that might reveal the dangers of certain drugs and medical interventions.”

Mr. Kennedy said the new division he is creating, the Administration for a Healthy America, would combine a number of agencies focused on substance abuse treatment and chemical safety, as well as the agency that administers courts that handle federal claims over vaccine injuries.

“We’re going to consolidate all of these departments and make them accountable to you, the American taxpayer and the American patient,” he said. “These goals will honor the aspirations of the vast majority of existing H.H.S. employees who actually yearn to make America healthy.”

Advertisement

Michael Gold contributed reporting.

Health

New Wegovy pill offers needle-free weight loss — but may not work for everyone

Published

on

New Wegovy pill offers needle-free weight loss — but may not work for everyone

NEWYou can now listen to Fox News articles!

The first oral GLP-1 medication for weight loss has been approved for use in the U.S.

The Wegovy pill, from drugmaker Novo Nordisk, was cleared by the Food and Drug Administration to reduce excess body weight, maintain long-term weight reduction and lower the risk of major cardiovascular events.

Approval of the once-daily 25mg semaglutide pill was based on the results of two clinical trials — the OASIS trial program and the SELECT trial.

WEIGHT-LOSS DRUGS NOW LINKED TO CANCER PROTECTION IN WOMEN, MAJOR NEW STUDY REVEALS

Advertisement

The Wegovy pill demonstrated a mean weight loss of 16.6% in the OASIS 4 trial among adults who were obese or overweight and had one or more comorbidities (other medical conditions), according to a press release. In the same trial, one in three participants experienced 20% or greater weight loss.

The first oral GLP-1 medication for weight loss has been approved for use in the U.S. (iStock)

Novo Nordisk reported that the weight loss achieved with the pill is similar to that of injectable Wegovy and has a similar safety profile.

WEIGHT LOSS DRUGS COULD ADD YEARS TO AMERICANS’ LIVES, RESEARCHERS PROJECT

“With today’s approval of the Wegovy pill, patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy injection,” said Mike Doustdar, president and CEO of Novo Nordisk, in the press release.

Advertisement

Novo Nordisk reported that the weight loss achieved with the pill is similar to that of injectable Wegovy and has a similar safety profile. (James Manning/PA Images via Getty Images)

“As the first oral GLP-1 treatment for people living with overweight or obesity, the Wegovy pill provides patients with a new, convenient treatment option that can help patients start or continue their weight-loss journey.”

POPULAR WEIGHT-LOSS DRUGS COULD TAKE THE EDGE OFF YOUR ALCOHOL BUZZ, STUDY FINDS

The oral GLP-1 is expected to launch in the U.S. in early January 2026. Novo Nordisk has also submitted oral semaglutide for obesity to the European Medicines Agency (EMA) and other regulatory authorities.

“Most side effects will be GI-related and should be similar to the injectable, such as nausea, vomiting and constipation,” an expert said. (iStock)

Advertisement

Dr. Sue Decotiis, a medical weight-loss doctor in New York City, confirmed in an interview with Fox News Digital that studies show oral Wegovy is comparable to the weekly injectable, just without the needles.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Although the pill may result in better compliance and ease of use, Decotiis warned that some patients may not absorb the medication through the gastrointestinal tract as well as with the injectable version due to individual idiosyncrasies in the body.

“Most side effects will be GI-related and should be similar to the injectable, such as nausea, vomiting and constipation,” she said.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

“In my practice, I have found tirzepatide (Mounjaro and Zepbound) to yield more weight loss and fat loss than semaglutide by about 20%,” the doctor added. “This has been shown in studies, often [with] fewer side effects.”

More oral GLP-1s may be coming in 2026, according to Decotiis, including an Orforglipron application by Lilly and a new combination Novo Nordisk drug, which is pending approval later next year.

One expert warned that some patients may not absorb the medication through the gastrointestinal tract as well as with the injectable version. (iStock)

“There will be more new drugs available in the future that will be more effective for patients who are more insulin-resistant and have not responded as well to semaglutide and/or tirzepatide,” the doctor said. “This is great news, as novel drugs affecting more receptors mean better long-term results in more patients.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

As these medications become cheaper and easier to access, Decotiis emphasized that keeping up with healthy lifestyle habits — including proper nutrition with sufficient protein and fiber, as well as increased hydration — is essential to ensuring lasting results.

CLICK HERE FOR MORE HEALTH STORIES

“If not, patients will regain weight and could lose muscle and not enough body fat,” she said.

Fox News Digital reached out to Novo Nordisk for comment.

Advertisement
Continue Reading

Health

Common household chemicals linked to increased risk of serious neurological condition

Published

on

Common household chemicals linked to increased risk of serious neurological condition

NEWYou can now listen to Fox News articles!

A study from Sweden’s Uppsala University discovered a link between microplastics and multiple sclerosis (MS).

The research, published in the journal Environmental International, discovered that exposure to two common environmental contaminants, PFAS and PCBs, could increase the risk of the autoimmune disease.

PFAS, or per- and polyfluoroalkyl substances, known as “forever chemicals,” are used in some common household products, such as non-stick cookware, textiles and cleaning products. They have also been found in drinking water throughout the U.S., according to the U.S. Environmental Protection Agency.

COMMON CLEANING CHEMICAL TIED TO SPIKE IN LIVER DISEASE ACROSS US, RESEARCHERS SAY

Advertisement

PCBs, or polychlorinated biphenyls, are toxic industrial chemicals once widely used in electrical equipment before being banned decades ago, as stated by the National Institute of Environmental Health Sciences.

The new study findings were based on blood samples of 1,800 Swedish individuals, including about 900 who had recently been diagnosed with MS, according to a university press release.

PFAS, or per- and polyfluoroalkyl substances, known as “forever chemicals,” are used in some common household products, including non-stick cookware. (iStock)

The first phase of the trial studied 14 different PFAS contaminants and three substances that appear when PCBs are broken down in the body. These were then investigated for a link to the odds of diagnosis.

‘FOREVER CHEMICALS’ FOUND IN US DRINKING WATER, MAP SHOWS ‘HOT SPOTS’ OF HIGHEST LEVELS

Advertisement

“We saw that several individual substances, such as PFOS and two hydroxylated PCBs, were linked to increased odds for MS,” lead study author Kim Kultima said in a statement. “People with the highest concentrations of PFOS and PCBs had approximately twice the odds of being diagnosed with MS, compared to those with the lowest concentrations.”

The researchers then examined the combined effects of these substances and found that the mixture was also linked to increased risk.

CLICK HERE FOR MORE HEALTH STORIES

Fellow researcher Aina Vaivade noted that risk assessments should consider chemical mixtures, not just individual exposures, because people are typically exposed to multiple substances at the same time.

“We saw that several individual substances, such as PFOS and two hydroxylated PCBs, were linked to increased odds for MS,” the lead study author said. (iStock)

Advertisement

The final phase of the study investigated the relationship between inheritance, chemical exposure and the odds of MS diagnosis, revealing that those who carry a certain gene variant actually have a reduced MS risk.

However, individuals who carried the gene and had higher exposure to PFOS a singular type of chemical in the PFAS family had an “unexpected” increased risk of MS.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“This indicates that there is a complex interaction between inheritance and environmental exposure linked to the odds of MS,” Kultima said. 

“We therefore think it is important to understand how environmental contaminants interact with hereditary factors, as this can provide new knowledge about the genesis of MS and could also be relevant for other diseases.”

Advertisement

Multiple sclerosis is a disease that leads to the breakdown of the protective covering of the nerves, according to Mayo Clinic. (iStock)

Fox News senior medical analyst Dr. Marc Siegel commented on these findings in an interview with Fox News Digital.

“MS is a complex disease that is somewhat autoimmune and somewhat post-inflammatory,” said Siegel, who was not involved in the study. “Epstein-Barr virus infection greatly increases the risk of MS.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“There is every reason to believe that environmental triggers play a role, including microplastics, and this important study shows a correlation, but not causation — in other words, it doesn’t prove that the microplastics caused MS.”

Advertisement

The study had some limitations, the researchers acknowledged, including that the chemical exposure was measured only once, at the time of blood sampling. This means it may not accurately represent participants’ long-term or past exposure levels relevant to MS development.

“There is every reason to believe that environmental triggers play a role.”

Fox News Digital reached out to several industry groups and manufacturers requesting comment on the potential link between PFAS chemicals and multiple sclerosis. 

Several have issued public statements, including the American Chemistry Council, which states on its website that “manufacturers and many users of today’s PFAS are implementing a variety of practices and technologies to help minimize environmental emissions.”

In April 2024, the EPA enacted a new federal rule that sets mandatory limits on certain PFAS chemicals in drinking water, aiming to reduce exposure. The agency also aims to fund testing and treatment efforts.

Advertisement

A woman working out outdoors takes a sip of water from a plastic bottle. (iStock)

Multiple sclerosis is a disease that leads to the breakdown of the protective coverings that surround nerve fibers, according to Mayo Clinic.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The immune system’s attack on these nerve sheaths can cause numbness, weakness, trouble walking and moving, vision changes and other symptoms, and can lead to permanent damage.

There is currently no cure for MS, Mayo Clinic reports, but treatment is available to manage symptoms and modify the course of the disease.

Advertisement

Continue Reading

Health

Natural Ozempic? 6 GLP-1 Foods That Work Just Like the Shot

Published

on

Natural Ozempic? 6 GLP-1 Foods That Work Just Like the Shot


Advertisement


6 GLP-1 Foods That Boost Weight Loss Naturally—No Injections Needed | Woman’s World




















Advertisement











Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Trending